Table 1.
Baseline characteristics of patients.
| Patients | All patients N = 182 | Chinese N = 85 | Non Chinese N = 97 | p |
|---|---|---|---|---|
| Gender (F) | 77 (42%) | 43 (51%) | 34 (35%) | 0.03 |
| Age (Y) | 46 (39–52) | 42 (36–52) | 48 (43–53) | 0.05 |
| Initial diagnosis | <0.01 | |||
| HBeAg negative infection | 90 (50%) | 37 (43%) | 53 (55%) | |
| HBeAg positive infection | 9 (5%) | 9 (11%) | 0 (0%) | |
| HBeAg positive chronic hepatitis | 32 (17%) | 25 (29%) | 7 (7%) | |
| HBeAg negative chronic hepatitis | 29 (16%) | 14 (17%) | 15 (16%) | |
| HBV acute hepatitis | 13 (7%) | 0 | 13 (13%) | |
| HBV/HDV coinfection | 9 (5%) | 0 | 9 (9%) | |
| HBV-DNA (detectable) | 90 (49%) | 46 (54%) | 44 (45%) | 0.27 |
| HBV-DNA (IU/mL) ** | 396 (17–4,780) | 1,090 (12–25,800) | 228 (0–2,545) | 0.03 |
| Antiviral Treatment (yes) | 76 (42%) | 41 (48%) | 35 (36%) | 0.02 |
| Transient elastography (kPa) | 5.8 (4–6) | 5.6 (4–6) | 6 (4–6) | 0.37 |
| Cirrhosis (yes) | 27 (15%) | 8 (9%) | 19 (20%) | 0.05 |
Quantitative: median (IQR), qualitative: number (%). ** Patients not receiving NAs.